script.reportAU
Register
← The record

Fentanyl, Transdermal Patch

Recommended · restricted PainRestrictedNot applicable line

chronic severe disabling pain not responding to non-narcotic analgesics

1
Submissions
2006–06
On the record
—
ICER range
Cost-min
Cost basis

Access path

1 submission · public record
  1. Mar 2006
    Recommended · restricted

    vs oral slow release morphine (OSRM)

  2. PBS listing · Restricted
RecommendedDeferredNot recommended

Cost-effectiveness

Cost-minimisation approach used; no ICER calculated

Decision context

Populationpatients with non-cancer related pain

Submission history

1 entries
DecidedOutcomeComparatorICEREvidence
Mar 2006 Recommended · restricted oral slow release morphine (OSRM) — RCT · Other

Similar precedents

By decision profile
Oxycodone, Tramadol, Codeine, Hydromorphone, Morphine, Tapentadol, Buprenorphine, Fentanyl76%Buprenorphine72%Methadone72%Hydromorphone Hydrochloride70%Buprenorphine Hydrochloride With Naloxone Hydrochloride69%Nicotine, Transdermal Patch68%Buprenorphine; Oxycodone + Naloxone68%Tapentadol67%

Regulatory · TGA

Label narrower than PBS population — PBAC restricts to severe disabling pain unresponsive to non-narcotic analgesics and excludes cancer pain; TGA label is broader.